Copyright
©The Author(s) 2023.
World J Clin Cases. Dec 26, 2023; 11(36): 8447-8457
Published online Dec 26, 2023. doi: 10.12998/wjcc.v11.i36.8447
Published online Dec 26, 2023. doi: 10.12998/wjcc.v11.i36.8447
Characteristics | No. % |
Gender | |
Male | 38 (90.4) |
Female | 4 (9.6) |
Age (yr) | |
Median | 66.1 |
Range | 41-84 |
Primary site | 4 (9.6) |
Bladder | 38 (90.4) |
Bladder, ureter, renal pelvis | 4 (9.6) |
Site of metastasis | |
Lymph node | 65 (53.2) |
Bone | 30 (24.6) |
Lung | 26 (21.3) |
Liver | 10 (8.1) |
Soft tissue | 10 (8.1) |
Other1 | 3 (2.4) |
- Citation: Öztürk H, Karapolat İ. Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer. World J Clin Cases 2023; 11(36): 8447-8457
- URL: https://www.wjgnet.com/2307-8960/full/v11/i36/8447.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v11.i36.8447